Clindamycin plus aminoglycoside may leads to lower treatment failure ‐ lincosamides versus penicillins compared with any other regimen (low certainty).
Clindamycin plus aminoglycoside showed no clear difference in severe complication ‐ lincosamides versus penicillins compared with any other regimen (low certainty).
Clindamycin plus aminoglycoside showed no clear difference in wound infection ‐ lincosamides versus penicillins compared with any other regimen (low certainty).
It is very uncertain whether clindamycin plus aminoglycoside changes allergic reaction ‐ lincosamides versus penicillins compared with any other regimen (very low certainty).
It is very uncertain whether antistaphylococcal cephalosporins C1 and C2 (1st and 2nd generation) changes maternal sepsis compared with broad spectrum penicillins plus betalactamase inhibitors P2+ ‐ all… (very low certainty).
Antistaphylococcal cephalosporins C1 and C2 (1st and 2nd generation) showed no clear difference in maternal endometritis compared with broad spectrum penicillins plus betalactamase inhibitors P2+ ‐ all… (low certainty).
It is very uncertain whether antistaphylococcal cephalosporins C1 and C2 (1st and 2nd generation) changes maternal wound infection compared with broad spectrum penicillins plus betalactamase inhibitors P2+ ‐ all… (very low certainty).
It is very uncertain whether antistaphylococcal cephalosporins C1 and C2 (1st and 2nd generation) changes maternal urinary tract infection compared with broad spectrum penicillins plus betalactamase inhibitors P2+ ‐ all… (very low certainty).
It is very uncertain whether antistaphylococcal cephalosporins C1 and C2 (1st and 2nd generation) changes maternal composite adverse effects compared with broad spectrum penicillins plus betalactamase inhibitors P2+ ‐ all… (very low certainty).